NCT04995900 is a NA clinical trial of Community education in Acute Coronary Syndrome, sponsored by Monash University.

Who is sponsoring NCT04995900?

NCT04995900 is sponsored by Monash University.

What drugs are being tested in NCT04995900?

Interventions in NCT04995900: Community education.

What condition does NCT04995900 study?

NCT04995900 studies Acute Coronary Syndrome, Myocardial Infarction, Acute.

Is NCT04995900 still recruiting?

NCT04995900 is currently completed. Last updated 15 June 2023.

Last reviewed 2023-06-15 · How we verify

NCT04995900

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Heart Matters: The Effectiveness of Heart Health Education in Regions at Highest-risk.

Completed NA Last updated 15 June 2023

What this trial tests

NA trial testing Community education in Acute Coronary Syndrome in 2,240 participants. Completed in 31 March 2023.

Timeline

1 February 2022

Primary endpoint
31 March 2023

31 March 2023

Quick facts

Lead sponsor	Monash University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	prevention
Enrollment	2,240
Start date	1 February 2022
Primary completion	31 March 2023
Estimated completion	31 March 2023
Sites	1 location across Australia

Drugs / interventions tested

Community education

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
Myocardial Infarction, Acute — all drugs for Myocardial Infarction, Acute →

Sponsor

Monash University

Who can join

18 and older, any sex, with Acute Coronary Syndrome or Myocardial Infarction, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate whether providing a targeted heart health education campaign to regions at high risk of heart attacks will improve ACS patient's symptom recognition and response. The intervention will be will be evaluated according to a cluster randomized, stepped wedged design. The clusters are eight local government areas (LGAs) in Victoria, Australia. The main primary outcome will be assessed in consecutive patients presenting to emergency departments from the six LGAs throughout the study period with an ED diagnoses of acute coronary syndrome.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Impact of a mass media campaign on presentations and ambulance use for acute coronary syndrome.
Eastwood K, Howell S, Nehme Z, Finn J, et al · · 2021 · cited 8× · PMID 34663748 · DOI 10.1136/openhrt-2021-001792
A protocol for the Heart Matters stepped wedge cluster randomised trial: The effectiveness of heart attack education in regions at highest-risk.
Bray JE, Nehme Z, Finn JC, Kasza J, et al · · 2023 · cited 1× · PMID 37555197 · DOI 10.1016/j.resplu.2023.100431
Heart Attack Education and EMS Response in High-Risk, Low EMS Usage Areas: A Stepped-Wedge Cluster-Randomized Trial.
Bray JE, Nehme Z, Finn JC, Kasza J, et al · · 2026 · PMID 42043820 · DOI 10.1001/jamanetworkopen.2026.8823

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Other Monash University trials

Trials by the same sponsor.

NCT07428473 — A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) · Phase 1 · not yet recruiting
NCT07300254 — Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: · recruiting
NCT06960967 — Effects of Chestnuts on Postprandial Glycaemic Response · NA · active not recruiting
NCT07202078 — Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) · Phase 2, PHASE3 · recruiting
NCT07202091 — Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) · Phase 2, PHASE3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04995900 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Monash University
Last refreshed: 15 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04995900.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing